25 Pulmonary Embolism Clinical Trials in Cincinnati, OH (2026)

Q: Are there pulmonary embolism clinical trials in Cincinnati?

Yes, there are 25 pulmonary embolism clinical trials currently recruiting in Cincinnati, OH.

Q: How do I join a clinical trial in Cincinnati?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Cincinnati research site will contact you.

Q: Are clinical trials in Cincinnati free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Pulmonary Embolism Studies in Cincinnati

NCT05110989Recruiting

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operati...

Cincinnati, OH5,000 participantsAtriCure, Inc.

View Study Details

NCT06121011Recruiting

A Global Prospective Observational Registry of Patients With Pompe Disease

This is a global, multicenter, prospective, observational registry of patients with Pompe disease, including those with late-onset pompe disease (LOPD) and infantile-onset pompe disease (IOPD). Both u...

Cincinnati, OH500 participantsAmicus Therapeutics

View Study Details

NCT07598708Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Narcolepsy Type 1 (NT1) and Narcolepsy Type 2 (NT2) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepiness \[EDS\]). People living with...

Cincinnati, OHPHASE2222 participantsCentessa Pharmaceuticals (UK) Limited

View Study Details

NCT02780297Recruiting

Prospective Research Rare Kidney Stones (ProRKS)

The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria, Dent disease and aden...

Cincinnati, OH220 participantsMayo Clinic

View Study Details

NCT06682208Recruiting

ES Catheter vs Cryoablation After Pectus Surgery

Participants will be randomized to receive ES catheter or cryoablation for pain management after the Nuss procedure. The goal of this study is to compare the following between the two groups: * Time ...

Cincinnati, OHNA176 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT06843538Recruiting

Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine f...

Cincinnati, OHPHASE3166 participantsTriHealth Inc.

View Study Details

NCT06933095Recruiting

Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia

The purpose of this placebo-controlled trial is to compare the effects of 24-weeks supplementation with LPC-DHA and TAG-DHA on cerebrospinal fluid and blood DHA levels, as well as biomarkers of centra...

Cincinnati, OHNA153 participantsUniversity of Cincinnati

View Study Details

NCT07540897Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

The purpose of this study is to measure decreases in daytime sleepiness, cataplexy (sudden loss of muscle tone), and disease symptoms in participants with NT1 when taking ALKS 2680 tablets compared wi...

Cincinnati, OHPHASE3150 participantsAlkermes, Inc.

View Study Details

NCT07207408Recruiting

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

This study will evaluate the immunogenicity, safety, and tolerability of rF1V-1018 vaccine...

Cincinnati, OHPHASE2148 participantsDynavax Technologies Corporation

View Study Details

NCT05334368Recruiting

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

This is a 52-week, randomized, placebo-controlled, double-blind, parallel group, multicenter study of depemokimab in adults with uncontrolled HES receiving standard of care (SoC) therapy. The study w...

Cincinnati, OHPHASE3123 participantsGlaxoSmithKline

View Study Details

NCT06997588Recruiting

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

This study is designed to demonstrate the efficacy and assess safety and tolerability of oral daily alpelisib in participants with PIK3CA-related overgrowth spectrum (PROS)....

Cincinnati, OHPHASE2104 participantsNovartis Pharmaceuticals

View Study Details

NCT06812078Recruiting

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

Idiopathic Hypersomnia (IH) is a condition where people feel extremely sleepy during the day, especially in the morning, even if they sleep a lot at night. They may have trouble waking up in the morni...

Cincinnati, OHPHASE296 participantsTakeda

View Study Details

NCT07363720Recruiting

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

The main aim of this study is to assess how effective TAK-861 is for treating narcolepsy type 1 and if this effect is maintained over time. Participants will take TAK-861 for a few months and if they ...

Cincinnati, OHPHASE388 participantsTakeda

View Study Details

NCT07015996Recruiting

Efficacy of Tezepelumab in Peanut Oral Immunotherapy

The proposed study is a proof-of-concept Phase 2, double-blind, randomized placebo-controlled clinical trial evaluating the safety and efficacy of tezepelumab and peanut Oral Immunotherapy (OIT) for t...

Cincinnati, OHPHASE262 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT07037771Recruiting

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

This multicenter, randomized, placebo-controlled study will evaluate the efficacy and safety of zodasiran subcutaneous (SC) injection in subjects 12 years of age and older with genetically or clinical...

Cincinnati, OHPHASE360 participantsArrowhead Pharmaceuticals

View Study Details

NCT07123155Recruiting

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

The purpose of this study is to evaluate the safety, pharmacodynamics (PD), and exploratory clinical efficacy of S-606001 in adult participants with LOPD as an add-on to ERT....

Cincinnati, OHPHASE245 participantsShionogi

View Study Details

NCT07223944Recruiting

A Gaucher Disease Gene Therapy Trial With FLT201

This study is a Phase 3, non-randomized, multicenter, efficacy and safety study in adult patients with Gaucher disease Type 1, on stable treatment with enzyme replacement therapy (ERT) or substrate re...

Cincinnati, OHPHASE345 participantsSpur Therapeutics

View Study Details

NCT05587712Recruiting

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World ...

Cincinnati, OHPHASE242 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06325813Recruiting

ADHD PreSMA Response Inhibition Therapy

ADHD children have abnormal inhibitory control, meaning they have trouble stopping themselves from doing something they should not do. This ability to control involves an area in the brain called the ...

Cincinnati, OHNA40 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT04808505Recruiting

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

This is a Phase 3, open-label, multicenter study to evaluate the safety, efficacy, PK, PD, and immunogenicity of cipaglucosidase alfa/miglustat treatment in ERT-experienced and ERT-naïve pediatric sub...

Cincinnati, OHPHASE336 participantsAmicus Therapeutics

View Study Details

NCT05836259Recruiting

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

This is a first-in-human, non-randomized, open-label study designed to evaluate the safety, tolerability, and pharmacodynamics (PD) of TN-201 in adult patients with symptomatic hypertrophic cardiomyop...

Cincinnati, OHPHASE130 participantsTenaya Therapeutics

View Study Details

NCT04555161Recruiting

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right hea...

Cincinnati, OHNA30 participantsAria CV, Inc

View Study Details

NCT04796012Recruiting

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

This trial is a multi-center, non-randomized, open-label Phase I/II study evaluating the feasibility and efficacy of vincristine, irinotecan, temozolomide, and atezolizumab in children with relapsed/r...

Cincinnati, OHPHASE123 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07192887Recruiting

Thebaine Urine Testing

To develop and validate a urine drug screen to detect thebaine....

Cincinnati, OH20 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT05642455Recruiting

SPEARHEAD-3 Pediatric Study

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....

Cincinnati, OHPHASE120 participantsAdaptimmune

View Study Details

About Pulmonary Embolism Clinical Trials in Cincinnati

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 25 pulmonary embolism clinical trials recruiting participants in Cincinnati, OH. These studies are seeking a combined 7,599 participants. Research is being sponsored by AtriCure, Inc., Amicus Therapeutics, Centessa Pharmaceuticals (UK) Limited and 18 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Cincinnati — FAQ

Are there pulmonary embolism clinical trials in Cincinnati?

Yes, there are 25 pulmonary embolism clinical trials currently recruiting in Cincinnati, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cincinnati?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cincinnati research site will contact you about next steps.

Are clinical trials in Cincinnati free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cincinnati studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 25 active trials in Cincinnati are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 19, 2026 from ClinicalTrials.gov